{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-068733","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.183012+00:00","generated_at":"2026-06-01T06:16:33.345473+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Entero Therapeutics replaces auditor Mazars with Forvis Mazars effective June 1, 2024","bullets":["Mazars USA LLP resigned after its partners and employees joined FORVIS LLP; the combined firm is now Forvis Mazars LLP.","No adverse opinions, disagreements, or reportable events occurred in fiscal years 2022 or 2023 during Mazars' tenure.","Audit committee appointed Forvis Mazars as new independent registered public accounting firm, subject to stockholder ratification.","Mazars' letter to the SEC regarding the change is filed as Exhibit 16.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-068733","json":"https://secwatch.observer/filing/0001104659-24-068733.json","markdown":"https://secwatch.observer/filing/0001104659-24-068733.md","text":"https://secwatch.observer/filing/0001104659-24-068733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/0001104659-24-068733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924068733/tm2416518d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:16:33.345473+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}